Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Provention Bio stock

Learn how to easily invest in Provention Bio stock.

Provention Bio Inc is a biotechnology business based in the US. Provention Bio shares (PRVB) are listed on the NASDAQ and all prices are listed in US Dollars. Provention Bio employs 59 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Provention Bio

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PRVB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Provention Bio stock price (NASDAQ: PRVB)

Use our graph to track the performance of PRVB stocks over time.

Provention Bio shares at a glance

Information last updated 2022-01-18.
Latest market close$4.29
52-week range$4.36 - $15.98
50-day moving average $6.17
200-day moving average $6.85
Wall St. target price$15.64
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.97

Buy Provention Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Stocks
$0
0%
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$0
$1 per month
$5
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Public
Stocks, ETFs, Cryptocurrency
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Provention Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Provention Bio price performance over time

Historical closes compared with the close of $4.29 from 2022-01-20

1 week (2022-01-13) -7.54%
1 month (2021-12-18) N/A
3 months (2021-10-22) -30.92%
6 months (2021-07-22) -30.36%
1 year (2021-01-22) -71.81%
2 years (2020-01-22) -75.26%
3 years (2019-01-22) 79.50%
5 years (2017-01-18) N/A

Provention Bio financials

Revenue TTM $678,000
Gross profit TTM $0
Return on assets TTM -49.38%
Return on equity TTM -89.93%
Profit margin 0%
Book value $2.12
Market capitalisation $293.4 million

TTM: trailing 12 months

Provention Bio share dividends

We're not expecting Provention Bio to pay a dividend over the next 12 months.

Provention Bio share price volatility

Over the last 12 months, Provention Bio's shares have ranged in value from as little as $4.36 up to $15.98. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Provention Bio's is 2.7244. This would suggest that Provention Bio's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Provention Bio overview

Provention Bio, Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-6527, an oral CSF-1R inhibitor, which has completed Phase IIa clinical trial for the treatment of Crohn's disease; PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-101, a coxsackie virus B (CVB) vaccine for the prevention of acute CVB infections and onset of T1D; and PRV-015, which is in phase IIb clinical trial for the treatment of gluten-free diet non-responding celiac disease. The company has a license and collaboration agreement with Amgen Inc. for PRV-015, a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease; and a strategic collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co. , Ltd. to develop and commercialize PRV-3279, a bispecific antibody-based molecule targeting the B cell surface proteins CD32B and CD79B in Greater China.

Frequently asked questions

What percentage of Provention Bio is owned by insiders or institutions?
Currently 15.885% of Provention Bio shares are held by insiders and 36.404% by institutions.
How many people work for Provention Bio?
Latest data suggests 59 work at Provention Bio.
When does the fiscal year end for Provention Bio?
Provention Bio's fiscal year ends in December.
Where is Provention Bio based?
Provention Bio's address is: 55 Broad Street, Red Bank, NJ, United States, 07701
What is Provention Bio's ISIN number?
Provention Bio's international securities identification number is: US74374N1028
What is Provention Bio's CUSIP number?
Provention Bio's Committee on Uniform Securities Identification Procedures number is: 74374N102

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site